KLINGLER-FRANKS-RYDER-KRAUSE. 225 ILCS 85/25 from Ch. 111, par. 4145 410 ILCS 620/3.14 from Ch. 56 1/2, par. 503.14 Amends the Pharmacy Practice Act and the Illinois Food, Drug and Cosmetic Act. Provides that pharmacists may substitute generic brand drugs, provided that the selected drug has been rated therapeutically equivalent to the prescribed drug in the Orange book and is not a critical dose drug. Allows the Technical Advisory Council to consider drugs that require a prescription and are legally marketed in the United States according to FDA regulations. Defines "critical dose drug". Effective immediately. HOUSE AMENDMENT NO. 1. Deletes reference to: 410 ILCS 620/3.14 from Ch. 56 1/2, par. 503.14 Deletes everything after the enacting clause. Amends the Pharmacy Practice Act of 1987 to make technical changes in a Section relating to drug selection. 99-12-27 H FILED WITH CLERK 99-12-27 H ADDED AS A JOINT SPONSOR KLINGLER 99-12-27 H ADDED AS A JOINT SPONSOR FRANKS 99-12-27 H ADDED AS A JOINT SPONSOR RYDER 99-12-27 H ADDED AS A JOINT SPONSOR KRAUSE 00-01-05 H FIRST READING 00-01-05 H REFERRED TO HOUSE RULES COMMITTEE RULES 00-01-19 H PRIMARY SPONSOR CHANGED TO KLINGLER 00-01-26 H ASSIGNED TO COMMITTEE EXECUTIVE 00-02-16 H AMENDMENT NO. 01-EXECUTIVE H 00-02-16 H ADOPTED 00-02-16 H DO PASS AMENDED/SHORT DEBATE 012-000-000 HEXC 00-02-16 H PLACED CALENDAR 2ND READING-SHORT DEBATE 00-02-29 H SECOND READING-SHORT DEBATE 00-02-29 H HELD ON CAL ORDER 2ND RDG - SHORT DEBATE 00-03-03 H RE-REFERRED TO RULES COMM/RULE 19(A) RULES HRUL 01-01-09 H SESSION SINE DIE END OF INQUIRY Full Text Bill Summary